Crsp stock forecast 2025.
According to 2 stock analysts, the average 12-month stock price forecast for DNA stock stock is $1.88, which predicts an increase of 45.74%. The lowest target is $1.25 and the highest is $2.50. On average, analysts rate DNA stock stock as a sell.
General Motors Company () Stock Market info Recommendations: Buy or sell General Motors stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the General Motors share forecasts, stock quote and buy / sell signals below.According to present data General Motors's GM shares and potentially its market …In the last quarter, shares of CRISPR Therapeutics CRSP have gained 24.1% against the industry ’s 3.4% fall. The steep rise in the stock price can be associated with the completion of the ...Nov 1, 2023 · Forecast for December 2025. It is predicted that the price of one CRISPR Therapeutics share in will be in the range of $52.12 to $60.68. The width of this range will be $8.56 (14.10%). The average price is $54.03, which is $0.17 less than the average price of the previous month. The Roku Inc - Class A stock forecast is 205.24788816489 USD for 2024 November 30, Saturday; and 1033.706 USD for 2028 November 30, Thursday with technical analysis. Roku Inc - Class A (ROKU) stock price prediction is 205.24788816489 USD.CRISPR Therapeutics AG Stock Forecast, CRSP stock price prediction. Price target in 14 days: 83.094 USD. ... CRISPR Therapeutics AG Stock Price Forecast for 2025 ...
Q1 2024 EPS Estimate Trends. Current. -$1.61. 1 Month Ago. -$1.85. 3 Months Ago. -$1.85. CRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst ...The stock is covered by 27 analysts and has a consensus price target of $83.78 which would be a 48% gain from the stock’s price as of this writing. Vertex Pharmaceuticals (VRTX) Source: Pavel ...We asked three Motley Fool contributors to pick beaten-down stocks they think can deliver 5x gains by 2030. Here's why they chose CRISPR Therapeutics ( CRSP -0.74%), Ginkgo Bioworks Holdings ( DNA ...
CRSP stock has fallen 16% over the last month (twenty-one trading days), after a rise in bond yields, along with rising concerns over the spread of a newer Covid-19 variant - Omicron - led to a ...
By 2025, Amazon’s stock price should reach $5,000, and by 2028 it will most likely hit about $10,000, give or take 20%.”. — Jana Kane, LiteForex. AMZN stock was down 7.1% as of Friday ...Find the latest CRISPR Therapeutics AG CRSP analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range …Stock Price Forecast. The 22 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 81.00, with a high estimate of 220.00 and a low estimate of 42.00. The median estimate represents a +17.27% increase from the …The weighted average target price per CRISPR Therapeutics share in Dec 2023 is: 68.02. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 15.330% volatility is expected. CRISPR Therapeutics stock price predictions for 2023 using artificial intelligence.It's being developed as a one-time curative treatment for two blood disorders, sickle cell disease and beta thalassemia. Regulators in the U.S., the U.K., and Europe are reviewing the candidate as ...
See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...CRSP Stock 12 Months Forecast. Based on 16 Wall Street analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. The average price target is $85.25 with a high forecast of $220.00 and a low forecast of $42.00. The average price target represents a 21.84% change from the last price of $69.97. Find real-time SHEL - Shell PLC stock quotes, company profile, news and forecasts from CNN Business.Nov 30, 2023 · C3.ai Stock Forecast 2023. $27.50. In the last five quarters, C3.ai’s Price Target has risen from $25.42 to $26.09 - a 2.64% increase. Two analysts predict that C3.ai’s share price will increase in the coming year, reaching $27.50. This would represent an increase of 5.4%. The latest CRISPR Therapeutics stock prices, stock quotes, news, and CRSP history to help you invest and trade smarter. ... The 68 analysts offering price forecasts for CRISPR Therapeutics have a ...Upgrade: " Piper Sandler analyst Edward Tenthoff with an overweight recommendation and $180 per share target on CRISPR (CRSP), urges investors to buy the dip. Tenthoff argues that data “validate CTX110 and CRISPR’s allogeneic CAR-T pipeline” with the company planning to expand the study." I agree with this guy!:-) 6.
Find real-time UBER - Uber Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.For TELADOC HEALTH INC stock forecast for 2023, 2 predictions are offered for each month of 2023 with average TELADOC HEALTH INC stock forecast of $19.58, a high forecast of $20.12, and a low forecast of $19.04. The average TELADOC HEALTH INC stock forecast 2023 represents a 4.7% increase from the last price of $18.7000007629395.Discover historical prices for CRSP stock on Yahoo Finance. View daily, weekly or monthly format back to when CRISPR Therapeutics AG stock was issued.The Upstart Holdings stock prediction for 2025 is currently $ 64.08, assuming that Upstart Holdings shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 141.45% increase in the UPST stock price.CRISPR Therapeutics AG (NASDAQ:CRSP) CRISPR Therapeutics AG. 68.97. Delayed Data. As of 3:59pm ET. -1.69 / -2.39%. Today’s Change. 37.55. Today ||| 52-Week Range.CRSP Stock 12 Months Forecast. Based on 16 Wall Street analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. The average price target is $85.25 with a high forecast of $220.00 and a low forecast of $42.00. The average price target represents a 21.84% change from the last price of $69.97. NEW YORK, Jan. 14, 2020 /PRNewswire/ --The Global Sports Analytics Market size is expected to reach $4.3 billion by 2025, rising at a market growt... NEW YORK, Jan. 14, 2020 /PRNewswire/ -- The Global Sports Analytics Market size is expecte...
Analysts expect revenue growth at 8% this year and further acceleration above double digits through 2025. EPS growth is also at ~25 for 2024 and 2025, respectively — very attractive at these levels.
The average CRISPR Therapeutics AG stock forecast 2024 represents a -25.46% decrease from the last price of $68.6500015258789. For CRISPR Therapeutics AG stock forecast for 2025, 12 predictions are offered for each month of 2025 with average CRISPR Therapeutics AG stock forecast of $49.41, a high forecast of $51.16, and a low forecast of $46.49. Target values for the price of one CRISPR Therapeutics share for Feb 2026. The weighted average target price per CRISPR Therapeutics share in Feb 2026 is: 39.08. In Feb, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 15.704% volatility is expected. Pessimistic target level: 35.58.1.76%. $20.2M. Plandai Biotechnology Inc. -20.00%. $1.94M. CRSP | Complete CRISPR Therapeutics AG stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.11 thg 1, 2023 ... Thanks to the solid financial performance, the company's share price was up over 97% in the last year. ... CRSP +0.36%. More Related Articles.Oct 15, 2020 · CRISPR Therapeutics AG (CRSP) stock price prediction is 130.64207402132 USD. The CRISPR Therapeutics AG stock forecast is 130.64207402132 USD for 2024 November 24, Sunday; and 586.145 USD for 2028 November 24, Friday with technical analysis. You value AMD way out in 2025 with a multiple of 25, which is around the current market multiple. The market grows on average around 5-6% per year. Even in 2025, AMD will be growing far faster ...People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Nikola Corp () Stock Market info Recommendations: Buy or sell Nikola stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Nikola share forecasts, stock quote and buy / sell signals below.According to present data Nikola's NKLA shares and potentially its market environment have been in bearish cycle last 12 …According to our CRISPR Therapeutics AG stock prediction for 2025, CRSP stock will be priced at $ 114.05 in 2025. This forecast is based on the stock’s average …
You value AMD way out in 2025 with a multiple of 25, which is around the current market multiple. The market grows on average around 5-6% per year. Even in 2025, AMD will be growing far faster ...
We asked three Motley Fool contributors to pick beaten-down stocks they think can deliver 5x gains by 2030. Here's why they chose CRISPR Therapeutics ( CRSP -0.74%), Ginkgo Bioworks Holdings ( DNA ...
Nov 19, 2023 · CRISPR Therapeutics Stock Up 14.6 %. NASDAQ:CRSP opened at $67.89 on Friday. The company’s 50 day moving average price is $46.64 and its 200-day moving average price is $53.09. CRISPR Therapeutics has a 52 week low of $37.55 and a 52 week high of $72.00. The stock has a market cap of $5.39 billion, a price-to-earnings ratio of -15.19 and a ... 8 thg 8, 2022 ... BVPS Estimate. 2022, -8.64, 22.53. 2023, -7.5, 15.03. 2024, -3.84, 11.19. 2025 ... Might the recent decline in CRSP's share price have an impact ...Based on short-term price targets offered by 37 analysts, the average price target for CrowdStrike Holdings comes to $201.46. The forecasts range from a low of $162.00 to a high of $245.00. The ...Be the first to know when Wall Street analysts revise their CRWD stock forecasts and price targets. Get Free CRWD Updates. CRWD stock forecasts by analyst. All ... On average, 13 Wall Street analysts forecast CRWD's revenue for 2025 to be $933,992,560,162, with the lowest CRWD revenue forecast at $920,170,065,158, and the highest CRWD revenue ...See the latest CRISPR Therapeutics AG stock price (CRSP:XNAS), related news, valuation, dividends and more to help you make your investing decisions.NEW YORK, Jan. 14, 2020 /PRNewswire/ --The Global Sports Analytics Market size is expected to reach $4.3 billion by 2025, rising at a market growt... NEW YORK, Jan. 14, 2020 /PRNewswire/ -- The Global Sports Analytics Market size is expecte...It's being developed as a one-time curative treatment for two blood disorders, sickle cell disease and beta thalassemia. Regulators in the U.S., the U.K., and Europe are reviewing the candidate as ...The latest CRISPR Therapeutics stock prices, stock quotes, news, and CRSP history to help you invest and trade smarter. ... The 68 analysts offering price forecasts for CRISPR Therapeutics have a ...
Wall Street Stock Market & Finance report, prediction for the future: You'll find the Editas Medicine share forecasts, stock quote and buy / sell signals below. According to present data Editas Medicine's EDIT shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).The latest CRISPR Therapeutics stock prices, stock quotes, news, and CRSP history to help you invest and trade smarter. ... The 68 analysts offering price forecasts for CRISPR Therapeutics have a ...Stock Price Forecast The 19 analysts offering 12-month price forecasts for MercadoLibre Inc have a median target of 1,700.00, with a high estimate of 2,120.00 and a low estimate of 1,500.00.Exela Technologies, Inc. (NASDAQ:XELA) issued its quarterly earnings results on Friday, November, 5th. The company reported ($1,080.00) earnings per share for the quarter, missing the consensus estimate of ($680.00) by $400.00. The business had revenue of $279.23 million for the quarter, compared to analysts' expectations of $310 …Instagram:https://instagram. single parent home loanjewish airlinewheeler real estate investment truststocks to buy under 5 Jul 6, 2023 · The stock is covered by 27 analysts and has a consensus price target of $83.78 which would be a 48% gain from the stock’s price as of this writing. Vertex Pharmaceuticals (VRTX) Source: Pavel ... And one particular stock to benefit is biotech CRISPR Therapeutics (CRSP 0.92%). The stock has advanced 24% so far this year. And this innovative company could be at the very beginning of its ... yield curve inversion chartjepi stocks Next reporting date. February 22, 2024. EPS forecast (this quarter) -$1.43. Annual revenue (last year) $52.1M. Annual profit (last year) -$474.2M. Net profit margin. cigna plus dental savings plan Microsoft Corp Revenue Forecast for 2023 - 2025 - 2030. In the last four years, Microsoft Corp's Revenue has grown by 57.55%, rising from $125.84B to $198.27B. For next year, analysts predict Revenue of $257.87B, which would mean an increase of 30.06%. Over the next seven years, experts predict that Microsoft Corp's Revenue will …15 brokers have issued 12-month price objectives for CRISPR Therapeutics' shares. Their CRSP share price targets range from $42.00 to $110.00. On average, they anticipate the company's share price to reach $69.88 in the next year. This suggests a possible upside of 2.9% from the stock's current price.Wall Street Stock Market & Finance report, prediction for the future: You'll find the AbCellera Biologics share forecasts, stock quote and buy / sell signals below. According to present data AbCellera Biologics's ABCL shares and potentially its market environment have been in bearish cycle last 12 months (if exists).